SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom

Anthropogenic transmission of SARS-CoV-2 to pet cats highlights the importance of monitoring felids for exposure to circulating variants. We tested cats in the United Kingdom for SARS-CoV-2 antibodies; seroprevalence peaked during September 2021–February 2022. The variant-specific response in cats t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyson, Grace B., Jones, Sarah, Logan, Nicola, McDonald, Michael, Marshall, Leigh, Murcia, Pablo R., Willett, Brian J., Weir, William, Hosie, Margaret J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202862/
https://www.ncbi.nlm.nih.gov/pubmed/37141617
http://dx.doi.org/10.3201/eid2906.221755
_version_ 1785045508306239488
author Tyson, Grace B.
Jones, Sarah
Logan, Nicola
McDonald, Michael
Marshall, Leigh
Murcia, Pablo R.
Willett, Brian J.
Weir, William
Hosie, Margaret J.
author_facet Tyson, Grace B.
Jones, Sarah
Logan, Nicola
McDonald, Michael
Marshall, Leigh
Murcia, Pablo R.
Willett, Brian J.
Weir, William
Hosie, Margaret J.
author_sort Tyson, Grace B.
collection PubMed
description Anthropogenic transmission of SARS-CoV-2 to pet cats highlights the importance of monitoring felids for exposure to circulating variants. We tested cats in the United Kingdom for SARS-CoV-2 antibodies; seroprevalence peaked during September 2021–February 2022. The variant-specific response in cats trailed circulating variants in humans, indicating multiple human-to-cat transmissions over a prolonged period.
format Online
Article
Text
id pubmed-10202862
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-102028622023-06-01 SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom Tyson, Grace B. Jones, Sarah Logan, Nicola McDonald, Michael Marshall, Leigh Murcia, Pablo R. Willett, Brian J. Weir, William Hosie, Margaret J. Emerg Infect Dis Dispatch Anthropogenic transmission of SARS-CoV-2 to pet cats highlights the importance of monitoring felids for exposure to circulating variants. We tested cats in the United Kingdom for SARS-CoV-2 antibodies; seroprevalence peaked during September 2021–February 2022. The variant-specific response in cats trailed circulating variants in humans, indicating multiple human-to-cat transmissions over a prolonged period. Centers for Disease Control and Prevention 2023-06 /pmc/articles/PMC10202862/ /pubmed/37141617 http://dx.doi.org/10.3201/eid2906.221755 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Tyson, Grace B.
Jones, Sarah
Logan, Nicola
McDonald, Michael
Marshall, Leigh
Murcia, Pablo R.
Willett, Brian J.
Weir, William
Hosie, Margaret J.
SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
title SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
title_full SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
title_fullStr SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
title_full_unstemmed SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
title_short SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
title_sort sars-cov-2 seroprevalence and cross-variant antibody neutralization in cats, united kingdom
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202862/
https://www.ncbi.nlm.nih.gov/pubmed/37141617
http://dx.doi.org/10.3201/eid2906.221755
work_keys_str_mv AT tysongraceb sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom
AT jonessarah sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom
AT logannicola sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom
AT mcdonaldmichael sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom
AT marshallleigh sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom
AT murciapablor sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom
AT willettbrianj sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom
AT weirwilliam sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom
AT hosiemargaretj sarscov2seroprevalenceandcrossvariantantibodyneutralizationincatsunitedkingdom

Ejemplares similares